Suchergebnisse - "Bonetto, Andrea"
-
1
STAT3 in the systemic inflammation of cancer cachexia
ISSN: 1084-9521, 1096-3634, 1096-3634Veröffentlicht: England Elsevier Ltd 01.06.2016Veröffentlicht in Seminars in cell & developmental biology (01.06.2016)“… Weight loss is diagnostic of cachexia, a debilitating syndrome contributing mightily to morbidity and mortality in cancer. Most research has probed mechanisms …”
Volltext
Journal Article -
2
Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition
ISSN: 1751-4266, 1751-4266Veröffentlicht: United States 01.12.2018Veröffentlicht in Current opinion in supportive & palliative care (01.12.2018)“… Cancer patients undergoing chemotherapy often experience very debilitating side effects, including unintentional weight loss, nausea, and vomiting. Changes in …”
Weitere Angaben
Journal Article -
3
Role of myokines and osteokines in cancer cachexia
ISSN: 1535-3699, 1535-3699Veröffentlicht: England 01.10.2021Veröffentlicht in Experimental biology and medicine (Maywood, N.J.) (01.10.2021)“… Cancer-induced muscle wasting, i.e. cachexia, is associated with different types of cancer such as pancreatic, colorectal, lung, liver, gastric and esophageal …”
Weitere Angaben
Journal Article -
4
Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia
ISSN: 1540-9538, 1540-9538Veröffentlicht: United States 07.06.2021Veröffentlicht in The Journal of experimental medicine (07.06.2021)“… Most patients with pancreatic adenocarcinoma (PDAC) suffer cachexia; some do not. To model heterogeneity, we used patient-derived orthotopic xenografts. These …”
Weitere Angaben
Journal Article -
5
Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism
ISSN: 2190-5991, 2190-6009, 2190-6009Veröffentlicht: Germany John Wiley & Sons, Inc 01.02.2019Veröffentlicht in Journal of cachexia, sarcopenia and muscle (01.02.2019)“… Background Cancer cachexia is a metabolic disorder involving perturbed energy balance and altered mitochondrial function. Chemotherapy is a primary treatment …”
Volltext
Journal Article -
6
Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways
ISSN: 1664-042X, 1664-042XVeröffentlicht: Switzerland Frontiers Media S.A 19.10.2016Veröffentlicht in Frontiers in physiology (19.10.2016)“… Cachexia represents one of the primary complications of colorectal cancer due to its effects on depletion of muscle and fat. Evidence suggests that …”
Volltext
Journal Article -
7
JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia
ISSN: 1522-1555, 1522-1555Veröffentlicht: United States 01.08.2012Veröffentlicht in American journal of physiology: endocrinology and metabolism (01.08.2012)“… Cachexia, the metabolic dysregulation leading to sustained loss of muscle and adipose tissue, is a devastating complication of cancer and other chronic …”
Weitere Angaben
Journal Article -
8
PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia
ISSN: 1530-6860, 1530-6860Veröffentlicht: United States 01.06.2019Veröffentlicht in The FASEB journal (01.06.2019)“… Cachexia is frequently accompanied by severe metabolic derangements, although the mechanisms responsible for this debilitating condition remain unclear …”
Weitere Angaben
Journal Article -
9
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
ISSN: 1940-087X, 1940-087XVeröffentlicht: United States MyJove Corporation 30.11.2016Veröffentlicht in Journal of visualized experiments (30.11.2016)“… Cancer cachexia is the progressive loss of skeletal muscle mass and adipose tissue, negative nitrogen balance, anorexia, fatigue, inflammation, and activation …”
Volltext
Journal Article -
10
STAT3 Activation in Skeletal Muscle Links Muscle Wasting and the Acute Phase Response in Cancer Cachexia
ISSN: 1932-6203, 1932-6203Veröffentlicht: United States Public Library of Science 20.07.2011Veröffentlicht in PloS one (20.07.2011)“… Cachexia, or weight loss despite adequate nutrition, significantly impairs quality of life and response to therapy in cancer patients. In cancer patients, …”
Volltext
Journal Article -
11
The Mitochondria-Targeting Agent MitoQ Improves Muscle Atrophy, Weakness and Oxidative Metabolism in C26 Tumor-Bearing Mice
ISSN: 2296-634X, 2296-634XVeröffentlicht: Switzerland Frontiers Media SA 22.03.2022Veröffentlicht in Frontiers in cell and developmental biology (22.03.2022)“… Cancer cachexia is a debilitating syndrome characterized by skeletal muscle wasting, weakness and fatigue. Several pathogenetic mechanisms can contribute to …”
Volltext
Journal Article -
12
HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia
ISSN: 1754-8403, 1754-8411, 1754-8411Veröffentlicht: England The Company of Biologists Ltd 01.01.2020Veröffentlicht in Disease models & mechanisms (01.01.2020)“… Colorectal cancer (CRC) is often accompanied by formation of liver metastases (LM) and skeletal muscle wasting, i.e. cachexia. Despite affecting the majority …”
Volltext
Journal Article -
13
Reduced rDNA transcription diminishes skeletal muscle ribosomal capacity and protein synthesis in cancer cachexia
ISSN: 1530-6860, 1530-6860Veröffentlicht: United States 01.02.2021Veröffentlicht in The FASEB journal (01.02.2021)“… Muscle wasting in cancer is associated with deficits in protein synthesis, yet, the mechanisms underlying this anabolic impairment remain poorly understood …”
Weitere Angaben
Journal Article -
14
PGC1α overexpression preserves muscle mass and function in cisplatin‐induced cachexia
ISSN: 2190-5991, 2190-6009, 2190-6009Veröffentlicht: Germany John Wiley & Sons, Inc 01.10.2022Veröffentlicht in Journal of cachexia, sarcopenia and muscle (01.10.2022)“… Background Chemotherapy induces a cachectic‐like phenotype, accompanied by skeletal muscle wasting, weakness and mitochondrial dysfunction. Peroxisome …”
Volltext
Journal Article -
15
Vincristine impairs musculoskeletal development in pediatric mice
ISSN: 1471-2407, 1471-2407Veröffentlicht: London BioMed Central 18.11.2025Veröffentlicht in BMC cancer (18.11.2025)“… Background Over 85% of children diagnosed with cancer now survive their disease, yet cancer and chemotherapy frequently associate with long-term health …”
Volltext
Journal Article -
16
Prevalence of ovarian cancer cachexia in patients undergoing debulking surgery at the University of Colorado between 2014–2024
ISSN: 2352-5789, 2352-5789Veröffentlicht: Elsevier 01.06.2025Veröffentlicht in Gynecologic oncology reports (01.06.2025)Volltext
Journal Article -
17
Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice
ISSN: 8756-3282, 1873-2763, 1873-2763Veröffentlicht: United States Elsevier Inc 01.07.2019Veröffentlicht in Bone (New York, N.Y.) (01.07.2019)“… Loss of bone and muscle mass are two major clinical complications among the growing list of chronic diseases that primarily affect elderly individuals …”
Volltext
Journal Article -
18
Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia
ISSN: 2190-5991, 2190-6009, 2190-6009Veröffentlicht: Germany John Wiley & Sons, Inc 01.08.2018Veröffentlicht in Journal of cachexia, sarcopenia and muscle (01.08.2018)“… Background Cachexia frequently occurs in women with advanced ovarian cancer (OC), along with enhanced inflammation. Despite being responsible for one third of …”
Volltext
Journal Article -
19
Skeletal Muscle Index's Impact on Discharge Disposition After Head and Neck Cancer Free Flap Reconstruction
ISSN: 1097-6817, 1097-6817Veröffentlicht: 01.07.2021Veröffentlicht in Otolaryngology-head and neck surgery (01.07.2021)“… To determine the role of skeletal muscle index (SMI) in the assessment of frailty and determination of discharge to post-acute care facilities (PACF) after …”
Weitere Angaben
Journal Article -
20
Impact of Sarcopenia on Outcomes of Autologous Head and Neck Free Tissue Reconstruction
ISSN: 1098-8947, 1098-8947Veröffentlicht: United States 01.06.2020Veröffentlicht in Journal of reconstructive microsurgery (01.06.2020)“… Sarcopenia has been implicated as a positive predictor of postsurgical complications. Its role in head and neck (H&N) free flap reconstruction has yet to be …”
Weitere Angaben
Journal Article